Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTI.L Regulatory News (CTI)

  • There is currently no data for CTI

Share Placement

20 Apr 2006 16:14

Cathay International Holdings Ld20 April 2006 Cathay International Holdings Limited 20 April 2006 CATHAY INTERNATIONAL HOLDINGS LIMITED (the "Company") Share Placement The Company announces that it has raised ÂŁ1,500,000 by way of a privateplacement of 15,000,000 new common shares of US$0.05 each (the "New CommonShares") at an issue price of 10 pence per share (the "Placing"). The issueprice was at a discount of approximately 9.38% to the average closing price ofthe Company's common shares for 90 consecutive trading days immediately prior todate of this announcement. The principal purpose of the Placing is to ensure that at least 25% of theCompany's listed securities are in public hands, as required by the listingrules of the UK Listing Authority (the "UKLA") and to introduce some newinvestors to the Company. It is intended that the funds raised will be used forgeneral working capital. The Company has the authority to issue the New Common Shares under the Placingpursuant to resolutions passed by shareholders at the special general meeting ofthe Company held on 16 August 2005. The New Common Shares represent 5.75% of the existing issued share capital ofthe Company and will represent 5.44% of the issued share capital of the Companyas enlarged as a result of the Placing. The New Common Shares will rank pari passu in all respect with all existingcommon shares of the Company. Application will be made to the UKLA for the NewCommon Shares to be admitted to the Official List and application will be madeto the London Stock Exchange for the New Common Shares to be admitted to tradingon its market for listed securities (together "Admission"). The issue of the NewCommon Shares is subject to Admission becoming effective on or before 31 May2006. It is expected that Admission will become effective and that dealings willcommence in the New Common Shares at 8.00 a.m. on 26 April 2006. Following the completion of the Placing, the interests of each director of theCompany (including any person connected to him) and the persons known to theCompany to be interested in three per cent. or more of the Company's capital areexpected to be as follows: Directors' interests in the Company New Common Shares Shareholding following % of enlarged subscribed in the Placing share capital the Placing A Shares Common Shares James Buchanan - 119,999 1,585,009 0.62 Wu Zhen Tao - 8,249,276 172,376,874 65.48 Stephen Hunt - - - - Patrick Sung - - - - John Cosson - 726 8,629 0.00 Note: Mr. Wu Zhen Tao's interest arises as a result of his indirect beneficialinterest in Cathay International Enterprises Limited. Substantial interests New Common Shares Shareholding following % of enlarged subscribed in the Placing share capital the Placing A Shares Common SharesCathay InternationalEnterprises Limited(through its 100% owned subsidiaries) - 8,249,276 172,376,874 65.48 Simon Phillips 3,000,000 92,075 16,827,321 6.13 New CapitalInvestment (Hong Kong) Limited - 864,513 9,121,679 3.62 Note: Cathay International Enterprises Limited is indirectly owned by a trustthe beneficiaries of which are Mr. Wu Zhen Tao and members of his family. Following the completion of the Placing, approximately 27.77% of the Company'slisted securities will be in public hands, for the purposes of the Listing Rulesof the UKLA. Enquiries: Stephen HuntDirector, Cathay International Holdings LimitedTelephone: + 852 2828 9289 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Apr 20157:00 amRNSGrant of Share Options
30th Mar 20157:35 amRNSRepeat of Annual Results Announcement RNS 7096I
27th Mar 201512:14 pmRNSAnnual Results for the Year Ended 31 December 2014
25th Mar 20157:00 amRNSHolding(s) in Company
12th Mar 20157:00 amRNSNotice of Annual Results 2014
5th Jan 20159:16 amRNSLansen's New Distribution Agreement
18th Dec 20148:36 amRNSLansen and Haotian Renew Supply Agreement
29th Aug 20149:26 amRNSInterim results for six months ended 30 June 2014
19th Aug 20147:00 amRNSNotice of Interim Results 2014
23rd May 201410:38 amRNSResult of AGM
19th May 20147:00 amRNSInterim Management Statement
7th Apr 20148:58 amRNSGrant of Share Options
31st Mar 20147:00 amRNSAcquisition of Sicorten Plus in the PRC
28th Mar 20148:47 amRNSAnnual Results for the Year Ended 31 December 2013
14th Mar 20147:00 amRNSNotice of Annual Results
19th Nov 20137:00 amRNSInterim Management Statement
15th Oct 201310:24 amRNSTransfer of Misoprostol Development Project
3rd Sep 20131:31 pmRNSLansen and Haotian Sign Supply Agreement
30th Aug 20139:42 amRNSInterim Results for the six months ended June 2013
19th Aug 20139:24 amRNSNotice of Interim Results
21st May 20137:00 amRNSResults of Annual General Meeting
16th May 20137:00 amRNSInterim Management Statement
11th Apr 20137:00 amRNSAnnual Report and Accounts
4th Apr 20139:03 amRNSGrant of Share Options
27th Mar 20138:30 amRNSAnnual Results for the Year Ended 31 December 2012
14th Mar 20139:33 amRNSNotice of Annual Results 2012
6th Mar 20138:30 amRNSCathay's subsidiary Lansen board change
26th Feb 201310:37 amRNSTR-1: Notification of Major Interest in Shares
23rd Nov 20128:55 amRNS1.5% holding in Zhejiang Starry Pharmaceutical Co.
19th Nov 20127:00 amRNSInterim Management Statement
29th Aug 201212:15 pmRNSTotal Voting Rights and Share Capital
29th Aug 20129:23 amRNSInterim results
15th Aug 20127:00 amRNSNotice of Interim Results
25th May 201211:26 amRNSResult of AGM
21st May 20127:00 amRNSAnnual Information Update
17th May 20127:00 amRNSInterim Management Statement
10th May 20127:00 amRNSLicense for collagen injectable filler
20th Apr 20129:15 amRNSAnnual Report and Accounts
3rd Apr 201210:50 amRNSGrant of Share Options
29th Mar 20129:32 amRNSAnnual Results for the Year Ended 31 December 2011
19th Mar 201210:00 amRNSNotification of Annual Results
27th Feb 20129:43 amRNSLansen Received Technology Endorsement
9th Jan 20129:00 amRNSLansen signs exclusive agreement
18th Nov 20117:00 amRNSInterim Management Statement
26th Oct 20119:47 amRNSLansen signs exclusive agreement with Ethypharm
25th Aug 20115:00 pmRNSInterim Results
15th Aug 201111:12 amRNSNotice of Interim Results
20th May 20117:00 amRNSAnnual Information Update
19th May 20117:00 amRNSInterim Management Statement
6th Apr 20117:00 amRNSTotal Voting Rights and Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.